As the demand for outsourcing increases at every level of biopharmaceutical development, emerging biopharma companies face the challenge of finding the ideal partner for bioanalytical services. Scorpius' Director of Analytical Development, Nicholas Raja, Ph.D., lays out the primary considerations when making this crucial choice.
Article
Meeting the Needs and Challenges of a Growing Bioanalytical Services Market
Read the Article
Learn more on:
- Identifying the right assays to evaluate a molecule
- The importance of a CRO’s flexibility and adaptability in building on existing assays
- Transparent communication and collaboration throughout the analytical development process
- Adjusting your R&D assays to meet standards for qualification and validation
- The role of comparative studies in bioanalytical development
With the global pharmaceutical analytical market projected to exceed $10 billion by 2026, the competition for biotech business will be fierce. In this article, learn how your company can experience the smoothest path to clinic and achieve speed to market across all stages of your bioanalytical development journey.